BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 12446059)

  • 21. Impact of cigarette smoking on extent of coronary artery disease and prognosis of patients with non-ST-segment elevation acute coronary syndromes: an analysis from the ACUITY Trial (Acute Catheterization and Urgent Intervention Triage Strategy).
    Robertson JO; Ebrahimi R; Lansky AJ; Mehran R; Stone GW; Lincoff AM
    JACC Cardiovasc Interv; 2014 Apr; 7(4):372-9. PubMed ID: 24630881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores.
    Almeda FQ; Hendel RC; Nathan S; Meyer PM; Calvin JE; Klein LW
    J Invasive Cardiol; 2003 Sep; 15(9):502-6. PubMed ID: 12947210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Greater benefit of early invasive strategy for unstable angina and non-ST elevation myocardial infarction in United States compared with non-United States patients: a TACTICS-TIMI 18 substudy.
    Herrmann HC; Murphy SA; Dibattiste PM; Delucca PT; Demopoulos LA; Gibson CM; Cannon CP
    Crit Pathw Cardiol; 2004 Jun; 3(2):95-100. PubMed ID: 18340148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Markers of low-grade inflammation and soluble cell adhesion molecules in Chinese patients with coronary artery disease.
    Fang L; Wei H; Mak KH; Xiong Z; Song J; Wang D; Lim YL; Chatterjee S
    Can J Cardiol; 2004 Dec; 20(14):1433-8. PubMed ID: 15614337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma vaspin concentrations are decreased in acute coronary syndrome, but unchanged in patients without coronary lesions.
    Zhang B; Peng W; Li H; Lu Y; Zhuang J; Wang K; Su Y; Xu Y
    Clin Biochem; 2013 Oct; 46(15):1520-5. PubMed ID: 23850850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association among leukocyte count, mortality, and bleeding in patients with non-ST-segment elevation acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] trial).
    Palmerini T; Généreux P; Mehran R; Dangas G; Caixeta A; Riva DD; Mariani A; Xu K; Stone GW
    Am J Cardiol; 2013 May; 111(9):1237-45. PubMed ID: 23411106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
    Valgimigli M; Campo G; Malagutti P; Anselmi M; Bolognese L; Ribichini F; Boccuzzi G; de Cesare N; Rodriguez AE; Russo F; Moreno R; Biondi-Zoccai G; Penzo C; Díaz Fernández JF; Parrinello G; Ferrari R
    JACC Cardiovasc Interv; 2011 Jan; 4(1):51-62. PubMed ID: 21251629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pre-existence of an acute coronary event predicts differences in biological parameters and clinical evolution among patients with longstanding stable angina.
    Sposito AC; Lemos PA; Maranhão RC; Mansur AP; Cesar LA; Ramires JA
    Int J Cardiol; 2003 Oct; 91(2-3):193-200. PubMed ID: 14559130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlates of coronary blood flow before and after percutaneous coronary intervention and their relationship to angiographic and clinical outcomes in the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis.
    Gibson CM; Dotani MI; Murphy SA; Marble SJ; Dauterman KW; Michaels AD; Dodge JT;
    Am Heart J; 2002 Jul; 144(1):130-5. PubMed ID: 12094199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benefit of an early invasive management strategy in women with acute coronary syndromes.
    Glaser R; Herrmann HC; Murphy SA; Demopoulos LA; DiBattiste PM; Cannon CP; Braunwald E
    JAMA; 2002 Dec; 288(24):3124-9. PubMed ID: 12495392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The thrombolysis in myocardial infarction risk score in unstable angina/non-ST-segment elevation myocardial infarction.
    Sabatine MS; Antman EM
    J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):89S-95S. PubMed ID: 12644346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
    Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina.
    Zebrack JS; Muhlestein JB; Horne BD; Anderson JL;
    J Am Coll Cardiol; 2002 Feb; 39(4):632-7. PubMed ID: 11849862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes.
    Bhatt DL; Chew DP; Lincoff AM; Simoons ML; Harrington RA; Ommen SR; Jia G; Topol EJ;
    Am J Cardiol; 2003 Jul; 92(2):136-40. PubMed ID: 12860213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) Trials.
    Damman P; van Geloven N; Wallentin L; Lagerqvist B; Fox KA; Clayton T; Pocock SJ; Hirsch A; Windhausen F; Tijssen JG; de Winter RJ
    JACC Cardiovasc Interv; 2012 Feb; 5(2):191-9. PubMed ID: 22361604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of prodromal angina pectoris and white blood cell count on outcome of patients with acute myocardial infarction.
    Ishihara M; Inoue I; Kawagoe T; Shimatani Y; Kurisu S; Hata T; Mitsuba N; Kisaka T
    Int J Cardiol; 2005 Aug; 103(2):150-5. PubMed ID: 16080973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiographic and clinical outcomes among patients with acute coronary syndromes presenting with isolated anterior ST-segment depression: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) substudy.
    Pride YB; Tung P; Mohanavelu S; Zorkun C; Wiviott SD; Antman EM; Giugliano R; Braunwald E; Gibson CM;
    JACC Cardiovasc Interv; 2010 Aug; 3(8):806-11. PubMed ID: 20723851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of the white blood cell count as a predictor of angiographic findings in an unselected population referred for coronary angiography.
    Cavusoglu E; Chopra V; Gupta A; Ruwende C; Yanamadala S; Eng C; Clark LT; Pinsky DJ; Marmur JD
    Am J Cardiol; 2006 Nov; 98(9):1189-93. PubMed ID: 17056325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current management of unstable angina: lessons from the TACTICS-TIMI 18 trial.
    Manoharan G; Adgey AA
    Am J Cardiovasc Drugs; 2002; 2(4):237-43. PubMed ID: 14727969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
    Cannon CP; Weintraub WS; Demopoulos LA; Vicari R; Frey MJ; Lakkis N; Neumann FJ; Robertson DH; DeLucca PT; DiBattiste PM; Gibson CM; Braunwald E;
    N Engl J Med; 2001 Jun; 344(25):1879-87. PubMed ID: 11419424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.